| Authors: |
Sambanthamoorthy S; Graduate Group in Immunology, University of California, Davis, Davis, California.; Bristol-Myers Squibb (United States) , Redwood City, California., Ren Y; Bristol-Myers Squibb (United States) , San Diego, California., Galvez TK; Bristol-Myers Squibb (United States) , San Diego, California., King B; Bristol-Myers Squibb (United States) , Lawrenceville, New Jersey., Liu SD; Bristol-Myers Squibb (United States) , Redwood City, California., Kidd BA; Bristol-Myers Squibb (United States) , Redwood City, California., Law DA; Bristol-Myers Squibb (United States) , Redwood City, California., Baumgarth N; Graduate Group in Immunology, University of California, Davis, Davis, California.; Department of Pathology, Microbiology, and Immunology, University of California, Davis, Davis, California.; Department of Molecular Microbiology and Immunology, Lyme and Tickborne Diseases Research and Education Institute, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.; Department of Molecular and Comparative Pathobiology, School of Medicine, Johns Hopkins University, Baltimore, Maryland. |
